Myxedema Coma in a Patient with Normal Thyroid Laboratory Tests after Laparoscopic Sleeve Gastrectomy; a Case Report
Journal of Practical Emergency Medicine,
Vol. 8 No. 1 (2021),
23 November 2020
,
Page e1
https://doi.org/10.22037/ijem.v8i1.32676
Abstract
Hypothyroidism is a common condition in the general population, which can be treated through replacing thyroid hormone with a proper dose. Myxedema coma is an extremely severe hypothyroidism, which manifests as hypothyroidism, hypotension, bradycardia, and altered mental state associated with severe hypothyroidism. In this article, we introduce a patient with a history of controlled secondary hypothyroidism, who, despite having normal thyroid test results, showed myxedema coma presentations after laparoscopic sleeve gastrectomy, and finally improved after treatment with oral levothyroxine.
- Coma; Myxedema; Thyroid Gland; Obesity, Morbid
How to Cite
References
BIGOS ST, RIDGWAY EC, KOURIDES IA, MALOOF F. Spectrum of pituitary alteration with mild and severe thyroid impairment. The Journal of Clinical Endocrinology & Metabolism. 1978;46(2):317-25.
Dutta P, Bhansali A, Masoodi SR, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Critical Care. 2008;12(1):R1.
Haupt M, Kurz A. Reversibility of dementia in hypothyroidism. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete. 1993;48(12):609.
Hylander B, Rosenqvist U. Treatment of myxoedema coma factors associated with fatal outcome. European Journal of Endocrinology. 1985;108(1):65-71.
Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. New England journal of medicine. 2001;344(7):501-9.
Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan. Journal of epidemiology. 2017;27(3):117-22.
Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman M, Burman K, et al. A diagnostic scoring system for myxedema coma. Endocrine Practice. 2014;20(8):808-17.
Rodriguez I, Fluiters E, Perez-Mendez L, Luna R, Páramo C, García Mayor R. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single. Journal of Endocrinology. 2004;180:347-50.
Salomo LH, Laursen AH, Reiter N, Feldt-Rasmussen U. Myxoedema coma: an almost forgotten, yet still existing cause of multiorgan failure. Case Reports. 2014;2014:bcr2013203223.
Westphal SA. Unusual presentations of hypothyroidism. The American journal of the medical sciences. 1997;314(5):333-7.
Yafit D, Carmel-Neiderman NN, Levy N, Abergel A, Niv A, Yanko-Arzi R, et al. Postoperative myxedema coma in patients undergoing major surgery: Case series. Auris Nasus Larynx. 2019;46(4):605-8.
YAMAMOTO T, FUKUYAMA J, FUJIYOSHI A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9(12):1167-74.
- Abstract Viewed: 687 times
- pdf (فارسی) Downloaded: 266 times
